Skip to results
Modify your search
NARROW
1-17 of 17
Authors: Carole D Mitnick
Sort by
Journal Article
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort Open Access
Uzma Khan and others
Clinical Infectious Diseases, ciae601, https://doi.org/10.1093/cid/ciae601
Published: 10 December 2024
Journal Article
Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan Open Access
Makhmujan Rashitov and others
Clinical Infectious Diseases, Volume 79, Issue 4, 15 October 2024, Pages 1046–1053, https://doi.org/10.1093/cid/ciae305
Published: 04 June 2024
Journal Article
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up Open Access
Sara M Sauer and others
Clinical Infectious Diseases, Volume 78, Issue 1, 15 January 2024, Pages 164–171, https://doi.org/10.1093/cid/ciad589
Published: 29 September 2023
Journal Article
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs Open Access
Ismat Lotia Farrukh and others
Clinical Infectious Diseases, Volume 78, Issue 1, 15 January 2024, Pages 144–148, https://doi.org/10.1093/cid/ciad445
Published: 22 August 2023
Journal Article
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs Open Access
Helena Huerga and others
Clinical Infectious Diseases, Volume 75, Issue 8, 15 October 2022, Pages 1307–1314, https://doi.org/10.1093/cid/ciac176
Published: 04 March 2022
Journal Article
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort Open Access
Catherine Hewison and others
Clinical Infectious Diseases, Volume 75, Issue 6, 15 September 2022, Pages 1006–1013, https://doi.org/10.1093/cid/ciac019
Published: 13 January 2022
Journal Article
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Market and City Bus Depot Workers in Lima, Peru Free
Marco Tovar and others
Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 343–346, https://doi.org/10.1093/cid/ciab323
Published: 21 April 2021
Journal Article
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis Free
Kwonjune J Seung and others
Clinical Infectious Diseases, Volume 71, Issue 2, 15 July 2020, Pages 415–418, https://doi.org/10.1093/cid/ciz1084
Published: 02 November 2019
Journal Article
Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study Free
Maha R Farhat and others
Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1364–1370, https://doi.org/10.1093/cid/cix556
Published: 03 August 2017
Journal Article
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis Free
Gregory J. Fox and others
Clinical Infectious Diseases, Volume 62, Issue 7, 1 April 2016, Pages 887–895, https://doi.org/10.1093/cid/ciw002
Published: 12 January 2016
Journal Article
Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death
Get access
Gustavo E. Velásquez and others
Clinical Infectious Diseases, Volume 59, Issue 1, 1 July 2014, Pages 9–15, https://doi.org/10.1093/cid/ciu209
Published: 11 April 2014
Journal Article
Concordance of Resistance Profiles in Households of Patients With Multidrug-Resistant Tuberculosis
Get access
Jonathan B. Parr and others
Clinical Infectious Diseases, Volume 58, Issue 3, 1 February 2014, Pages 392–395, https://doi.org/10.1093/cid/cit709
Published: 28 October 2013
Journal Article
EDITOR'S CHOICE
Aggressive Regimens for Multidrug-Resistant Tuberculosis Reduce Recurrence
Get access
Molly F. Franke and others
Clinical Infectious Diseases, Volume 56, Issue 6, 15 March 2013, Pages 770–776, https://doi.org/10.1093/cid/cis1008
Published: 07 December 2012
Journal Article
Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis
Get access
Kelly E. Dooley and others
Clinical Infectious Diseases, Volume 55, Issue 4, 15 August 2012, Pages 572–581, https://doi.org/10.1093/cid/cis487
Published: 21 May 2012
Journal Article
Recurrence after Treatment for Pulmonary Multidrug-Resistant Tuberculosis
Get access
Mercedes C. Becerra and others
Clinical Infectious Diseases, Volume 51, Issue 6, 15 September 2010, Pages 709–711, https://doi.org/10.1086/655892
Published: 15 September 2010
Journal Article
Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis
Get access
Karen R. Jacobson and others
Clinical Infectious Diseases, Volume 51, Issue 1, 1 July 2010, Pages 6–14, https://doi.org/10.1086/653115
Published: 01 July 2010
Journal Article
Risk Factors and Mortality Associated with Default from Multidrug-Resistant Tuberculosis Treatment
Get access
Molly F. Franke and others
Clinical Infectious Diseases, Volume 46, Issue 12, 15 June 2008, Pages 1844–1851, https://doi.org/10.1086/588292
Published: 15 June 2008
Advertisement
Advertisement